Answers are grounded in this paper and cite their sources.
Lactobacillus rhamnosus GG (LGG) is one of the most studied probiotic strains, with an immunological fingerprint that has evolved over three decades of research. The exponential growth of biomedical literature has created a scalability crisis exceeding human synthesis capacity. This study aimed to elucidate LGG’s immunomodulatory role using a zero-cost, high-speed, hybrid human-AI workflow, leveraging free Model-platform systems as a scalable screening tool accessible to any researcher regardless of institutional affiliation. An operative pipeline based on four specialized prompts was developed to interrogate three Model-platform systems architectures (Gemini 3 Flash, Perplexity Academic, and Claude Sonnet 4.6), screening 37 years of PubMed literature (1989–2026). Performance was benchmarked against a human-validated Gold Standard using Sensitivity, Specificity, and Spearman Correlation, with a “Semantic Floor” analysis investigating False Negatives. A paradigm shift emerged: historical studies (pre-2019) focused on mucosal barrier integrity and IgA production, while recent research (2019–2026) emphasizes complex molecular signaling (IL-22, Type-I Interferons, Inflammasome modulation). A consistent core fingerprint persisted, characterized by TNF-α/IL-6 suppression and IL-10 upregulation, while IFNg showed context-dependent dual modulation. Gemini 3 Flash showed superior sensitivity (0.93–0.97), while Perplexity Academic achieved near-perfect specificity (0.99) due to its Retrieval-Augmented Generation (RAG) architecture which mitigated hallucinations. The Spearman Heatmap revealed a correlation coefficient near zero between Gemini and Perplexity sessions, reflecting their divergent scoring dynamics. LGG research has shifted from mucosal barrier protection to complex molecular signaling. Synergy between different model-platform systems architectures allows researchers to act as AI-orchestrators, focusing on critical interpretation rather than mechanical extraction. Established knowledge on this subject. Lactobacillus rhamnosus GG (LGG) is one of the most studied probiotic strains, with a well-documented immunomodulatory profile. Biomedical literature is growing exponentially and model-platform systems are emerging as tools for accelerating evidence synthesis, but their reliability and complementarity in biomedical research remain poorly characterized. Significant and/or new findings of this study. We validated a zero-cost, hybrid human-AI pipeline using three distinct model-platform systems architectures to screen 37 years of PubMed literature on LGG. We identified a shift in LGG research, from mucosal barrier/IgA focus to a more recent interest in complex molecular signaling (IL-22, Type I IFN, inflammasome). A consistent core immunological fingerprint (TNF-α/IL-6 suppression, IL-10/IFN-γ upregulation) persisted across three decades. We defined a "Semantic Floor," including a novel "Title Trap" phenomenon, highlighting key limitations requiring human oversight in AI-assisted synthesis.
No takes yet. Share an insight, caveat, or question.
Rocca et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: